Kadcyla® Trastuzumab Emtansine Safety Reminder
ID:
GL-C50-15
juin 2014
Type of Content: Drug Safety, Guidelines & Advice, Clinical
Document Status: Current
Guideline Objective
Trastuzumab emtansine (Kadcyla®) and trastuzumab (Herceptin®) have look alike/sound alike names. They are not the same product and are not interchangeable. This document outlines recommendations made by the CCO Systemic Treatment to ensure safety.
Intended Guideline Users
Providers (Physicians, Pharmacists, Nurses)
Full Report (PDF) (291.33 Ko)